Connect with us

National

AstraZeneca shares slide even as the company’s coronavirus vaccine trial results show ‘promise’ – Business Insider Australia

AstraZeneca shares fell on Monday even after positive results from a trial involving its COVID-19 vaccine developed in partnership with Oxford University.

Published

on

post featured image
  • AstraZeneca shares slid on Monday despite positive news from the drugmaker’s first human COVID-19 vaccine trials.
  • The early-stage human trial data for the vaccine – which is being developed in conjunction with Oxford University – showed the results of 543 vaccinated volunteers.
  • The vaccine was able to generate immune responses in healthy volunteers, the results showed.
  • In early US trade, the company’s stock was down by around 2.7%.
  • Watch AstraZeneca trade …

    Click here to view the original article.